<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pancreatic polypeptide, peptide YY, and neuropeptide Y</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pancreatic polypeptide, peptide YY, and neuropeptide Y</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pancreatic polypeptide, peptide YY, and neuropeptide Y</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rodger A Liddle, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">J Thomas Lamont, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shilpa Grover, MD, MPH, AGAF</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 09, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Originally isolated in 1968 during the preparation of insulin, pancreatic polypeptide (PP) is the founding member of the pancreatic polypeptide family [<a href="#rid1">1,2</a>]. The PP family of peptides includes peptide YY (PYY) and neuropeptide Y (NPY), which were discovered based upon their chemical structure (possessing a carboxyl-terminal tyrosine amide) [<a href="#rid3">3-5</a>]. PP, PYY, and NPY are all 36 amino acids in length, and despite structural similarities, they are found in different locations throughout the gastrointestinal tract and nervous system and possess different biological actions. PP is expressed in endocrine cells of the gut and pancreas, PYY is located in enteroendocrine cells of the ileum and colon and nerves of the enteric nervous system, and NPY is found in the central and peripheral nervous system. This wide distribution suggests that these peptides regulate many different physiological processes.</p><p class="headingAnchor" id="H2"><span class="h1">MOLECULAR FORMS</span><span class="headingEndMark"> — </span>The pancreatic polypeptide (PP) peptides share a significant degree of sequence homology that produces a polyproline helix, an amphipathic alpha-helix, and an amidated carboxyl terminus, resulting in a hairpin fold known as the PP-fold (<a class="graphic graphic_figure graphicRef67136" href="/z/d/graphic/67136.html" rel="external">figure 1</a>) [<a href="#rid6">6</a>]. Although unusual for small peptides, it is believed that this tertiary structure is important for the peptides' biological activities.</p><p class="headingAnchor" id="H3"><span class="h1">TISSUE DISTRIBUTION</span><span class="headingEndMark"> — </span>Pancreatic polypeptide (PP) is secreted by specialized pancreatic islet cells (PP cells) that are distinct from those producing insulin, glucagon, or somatostatin [<a href="#rid7">7</a>].</p><p>Neuropeptide Y (NPY) is a principal neurotransmitter found in the central and peripheral nervous systems and is predominantly found in sympathetic neurons [<a href="#rid8">8-10</a>]. </p><p>Peptide YY (PYY) has been localized to enteroendocrine cells in the mucosa of the gastrointestinal tract and is most highly concentrated in the ileum and colon [<a href="#rid11">11</a>]. PYY is produced predominantly by L cells of the ileum and colon where it is colocalized with enteroglucagon. PYY is also produced in other enteroendocrine cells throughout the intestine [<a href="#rid12">12</a>]. It has long been held that enteroendocrine cells are elongated or "flask"-shaped cells that reside in the intestinal mucosa with their apical surface open to the lumen of the intestine. In this position, enteroendocrine cells can "sense" luminal contents such as food or bacteria. Stimulation of cells causes the release of hormones from the basal surface into the paracellular space, where they are taken up by blood vessels and carried to distant sites of action. However, a new concept for enteroendocrine cell function is now apparent with the discovery that PYY cells possess neuropods that extend from their basal surface (<a class="graphic graphic_figure graphicRef74542" href="/z/d/graphic/74542.html" rel="external">figure 2</a>) [<a href="#rid13">13,14</a>]. Neuropods contain many features typical of neurons, including synaptic boutons, neurofilaments, pre- and post-synaptic proteins, and small, clear synaptic vesicles. Moreover, it has been discovered that enteroendocrine cells connect directly with enteric nerves [<a href="#rid15">15</a>]. This new epithelial-neural circuit provides a pathway for the gut to connect directly to the brain. It is possible that this pathway is involved in how the brain senses gut contents.</p><p class="headingAnchor" id="H4"><span class="h1">RECEPTORS</span><span class="headingEndMark"> — </span>The biologic actions of the PP/PYY/NPY family of peptides result from binding to a multitude of receptor subtypes [<a href="#rid16">16</a>]. At present, five functional receptor subtypes have been identified, all of which are typical G protein-coupled receptors that have been designated "Y" receptors (<a class="graphic graphic_table graphicRef75135" href="/z/d/graphic/75135.html" rel="external">table 1</a>) [<a href="#rid17">17-21</a>]. These receptors signal through the GTP-binding proteins Gi/Go and inhibit adenylyl cyclase. Another mechanism for signaling also involves inhibition of calcium and potassium channels that have been demonstrated in cardiac myocytes and smooth muscle cells. A sixth Y receptor has been found in some species, but its function has not been clearly established [<a href="#rid22">22</a>]. (See  <a class="medical medical_review" href="/z/d/html/3804.html" rel="external">"Peptide hormone signal transduction and regulation"</a>.)</p><p class="headingAnchor" id="H5"><span class="h1">PEPTIDE RELEASE</span><span class="headingEndMark"> — </span>The pancreatic polypeptide (PP) family of peptides functions as endocrine, paracrine, and neurocrine transmitters. Neuropeptide Y (NPY) is a true neurotransmitter, being released from nerve terminals, while peptide YY (PYY) and PP are hormones acting in both a paracrine and endocrine manner. Following a meal, PP is released into the blood from PP cells of the pancreas via vagal-cholinergic stimulation [<a href="#rid23">23</a>]. PP concentrations also fluctuate with the myoelectric activity of the gastrointestinal tract. Plasma PP levels increase in phase with the periodic contraction and secretion of the gut, an effect that is abolished with ganglionic blockade [<a href="#rid24">24</a>]. There is growing evidence that gut microbiota influence the nervous system, and it is likely that this occurs through release of hormones such as PYY or through the enteroendocrine cell-neuronal connection described above [<a href="#rid25">25</a>].</p><p>In contrast to PP, PYY levels change very slowly and not to the same degree in response to a meal. Moreover, PYY release does not depend upon intact vagal input [<a href="#rid26">26</a>]. Meal-stimulated PYY release in humans occurs largely in response to ingested fat, primarily short-chain and polyunsaturated fatty acids [<a href="#rid27">27</a>]. Gastrointestinal diseases that cause malabsorption increase blood levels of PYY. In addition, surgical conditions that increase the delivery of food to the distal ileum and colon including small bowel resection, vertical band gastroplasty, Roux-en-Y gastric bypass, and jejunoileal bypass also elevate circulating PYY levels [<a href="#rid28">28</a>]. G protein-coupled receptor 119 (GPR119) agonists have been shown to stimulate PYY release (along with glucagon-like peptide 1 and glucose-dependent insulinotropic peptide), indicating that GPR119 may be directly involved in hormone secretion [<a href="#rid29">29</a>]. PYY cells, like other enteroendocrine cells, also possess taste receptors that are linked to PYY secretion [<a href="#rid30">30</a>].  </p><p>During inflammation, NPY is produced by T cells, macrophages, and dendritic cells [<a href="#rid31">31</a>].</p><p>The gut microbiota appear to modulate the release of hormones that are produced in the ileum and colon, including PYY [<a href="#rid32">32</a>]. These effects may be through direct actions of microbes themselves or microbial metabolites such as short-chain fatty acids [<a href="#rid33">33,34</a>]. As such, prebiotics or probiotics are being investigated as ways to manipulate behaviors like eating through effects on gastrointestinal hormone release</p><p class="headingAnchor" id="H6"><span class="h2">Physiological actions</span><span class="headingEndMark"> — </span>PP has a number of inhibitory actions that are believed to be important for both pancreatic and gastrointestinal function. Because many of its actions are local, it has been difficult to assess the magnitude of PP's effects in the pancreas; however, it is well recognized to inhibit pancreatic exocrine secretion [<a href="#rid35">35</a>]. In addition, PP has inhibitory effects on gallbladder contraction and gut motility [<a href="#rid36">36,37</a>], and may influence food intake, energy metabolism, and the expression of gastric ghrelin and hypothalamic peptides [<a href="#rid38">38</a>]. PYY inhibits vagally stimulated gastric acid secretion and other motor and secretory functions [<a href="#rid39">39-41</a>]. PYY-producing cells of the ileum are stimulated by incompletely digested nutrients, particularly fats. PYY released into the bloodstream can inhibit several gastrointestinal processes, including gastric emptying and intestinal motility, thus delaying the delivery of additional food to the intestine. This concept is known as the "ileal brake" and is believed to be mediated largely by PYY (<a class="graphic graphic_figure graphicRef62927" href="/z/d/graphic/62927.html" rel="external">figure 3</a>) [<a href="#rid42">42</a>]. Like PP, PYY also signals to the brain to reduce food intake by acting on Y2 receptors in the hypothalamus [<a href="#rid43">43</a>]. In the periphery, PYY induces lipolysis and improves glycemic control by increasing insulin sensitivity through a reduction in circulating fatty acids [<a href="#rid44">44</a>]. PYY may have a detrimental effect on bone density [<a href="#rid45">45</a>] by suppressing osteoblast activity via the Y1 receptor [<a href="#rid46">46</a>]. These findings are consistent with the observations that transgenic overexpression of PYY in mice reduced bone mass [<a href="#rid47">47</a>]. In contrast, PYY knockout mice exhibited increased bone mass.  </p><p>NPY is one of the most abundant peptides in the CNS and is the most potent known stimulant of food intake [<a href="#rid48">48</a>]. In the arcuate nucleus of the hypothalamus, NPY levels increase sharply under conditions of food deprivation, which leads to an increase in food intake to restore the homeostatic condition [<a href="#rid49">49</a>]. Peripherally, NPY affects vascular and gastrointestinal smooth muscle function by binding to the Y1 receptor and through its G protein stimulates phospholipase C, resulting in the accumulation of IP3 and increased cytosolic calcium [<a href="#rid6">6,36,50</a>]. NPY also has proinflammatory effects by virtue of activating immune cells that express NPY receptors. Specifically, NPY stimulates leukocyte migration and adhesion and activates macrophages to produce inflammatory cytokines such as IL-4, IL-12, and TNF-alpha [<a href="#rid51">51</a>].</p><p class="headingAnchor" id="H7"><span class="h1">CLINICAL IMPLICATIONS OF THE PP/PYY/NPY FAMILY OF PEPTIDES</span><span class="headingEndMark"> — </span>The observation that pancreatic polypeptide (PP) is secreted from the pancreas in response to vagal nerve stimulation has been used as a diagnostic test of vagal nerve function. Cephalic stimulation of the vagus nerve, such as occurs with sham feeding, stimulates release of PP that can be measured in the blood. However, following vagotomy this response is lost.</p><p>Although possessing a long evolutionary lineage, and many important effects on the gastrointestinal tract, no members of the PP family of peptides are used clinically as therapeutic agents. However, perhaps the most important possibilities pertain to regulation of food intake. An animal model overexpressing pancreatic polypeptide demonstrated reduced body weight and food intake [<a href="#rid52">52</a>] and protection against diet and genetic obesity [<a href="#rid53">53</a>]. Conversely, peptide YY (PYY) knock-out mice are predisposed to obesity and insulin resistance [<a href="#rid54">54</a>].</p><p>In addition, substantial data indicate that neuropeptide Y (NPY) and its receptor are potential targets for regulation of appetite and feeding and are involved in the pathogenesis of obesity [<a href="#rid55">55,56</a>]. Release of NPY and activation of the NPY Y2 receptor stimulate fat angiogenesis, macrophage infiltration, and the proliferation and differentiation of adipocytes, resulting in abdominal obesity and a metabolic syndrome-like condition [<a href="#rid56">56</a>]. The Y5 receptor has been proposed as an "appetite receptor," however other Y family receptors also play a role in this complex behavior. It was demonstrated in humans that aerobic exercise increased circulating PYY levels while suppressing hunger [<a href="#rid57">57</a>].</p><p>Animal models lacking various Y family receptors have been studied. Mice produced with an inactivated Y5 receptor manifested late-onset obesity, yet developed normally [<a href="#rid58">58</a>], while mice deficient in Y1 receptor expression demonstrated only mild reduction in daily food intake and NPY-stimulated feeding. However, after fasting, short-term feeding was significantly reduced in these animals [<a href="#rid59">59</a>]. Gene deletion of the Y2 receptor in mice resulted in increased food intake, body weight, and fat deposition, providing strong evidence for the importance of this receptor in regulating ingestive behavior [<a href="#rid60">60</a>]. Targeted overexpression in the dorsomedial hypothalamus increased food intake whereas ablation in this area reduced hyperphagia and obesity [<a href="#rid61">61</a>]. The ability to target specific neural pathways in the brain will be important for dissecting the location-specific functions of NPY in the regulation of energy metabolism.</p><p>Although PYY acutely inhibits insulin secretion, prolonged activation of Y1 receptors on pancreatic beta cells exerts beta cell protective effects [<a href="#rid62">62</a>]. Therefore, it has been proposed that PYY-based drugs could be used as a therapeutic strategy in the management of diabetes mellitus.</p><p>Ghrelin, originally discovered as a growth hormone receptor ligand, has been demonstrated to antagonize leptin action through activation of the NPY Y1 receptor [<a href="#rid38">38,63</a>]. Ghrelin is an acylated peptide that is produced in the stomach and hypothalamus and stimulates feeding and growth hormone release [<a href="#rid64">64,65</a>]. Intracerebroventricular injections of ghrelin stimulated feeding in rats that were deficient in growth hormone and this action was suppressed when the animals were treated with anti-ghrelin antibodies. Similarly, NPY antagonists abolished this effect. Furthermore, ghrelin treatment also enhanced NPY gene expression [<a href="#rid64">64</a>]. It appears ghrelin may be clinically useful as a growth hormone stimulant in cases of deficiency and/or as an appetite stimulant in patients with cachexia [<a href="#rid66">66</a>].</p><p>The PP family clearly has a role in feeding behavior. However, regulation of appetite is complex and involves many interacting components, including a number of signaling mechanisms [<a href="#rid67">67</a>]. Although the 36 amino acid form of PYY (PYY1-36) was the form originally isolated from intestine, a shortened form lacking the first two amino acids (PYY3-36) also exists and may play a physiological role in the regulation of food intake. In humans, PYY1-36 acts through four Y-receptor subtypes, Y1, Y2, Y4 and Y5, while PYY3-36 is a specific agonist at the Y2 receptor.</p><p>Both PYY1-36 and PYY3-36 cross the blood-brain barrier and participate in the regulation of food intake and satiety. Activation of the Y1 and Y5 receptors by PYY1-36 has been shown to increase food intake and cause weight gain, whereas activation of the Y2 receptor by PYY3-36 inhibits NPY release from cells of the arcuate nucleus, thereby decreasing food intake and resulting in weight loss [<a href="#rid28">28</a>]. A study in lean and obese humans demonstrated that infusion of PYY3-36 decreased caloric intake by approximately 30 percent compared with placebo when subjects were offered a buffet meal [<a href="#rid68">68</a>]. In addition, 24 hour caloric intake was reduced. Obese adults and children have significantly lower fasting PYY levels and levels correlate inversely with body mass index [<a href="#rid69">69</a>].These observations suggest that PYY has an important regulatory role in feeding behavior, potentially offering a target for drug development.</p><p>In a large cohort of extremely obese individuals, a genetic variant in the coding region of the PYY gene (PYY Q62P) exhibiting familial segregation has been identified [<a href="#rid70">70</a>]. Interestingly, unlike wild-type PYY, the mutated PYY protein demonstrated altered receptor binding and failed to reduce food intake when tested in vivo. These data suggest that rare mutations in PYY may influence human susceptibility to obesity.</p><p>In addition to effects on feeding, PYY has been shown to influence other behaviors such as perception, judgment, learning, and memory [<a href="#rid71">71</a>]. These effects may be through dopaminergic neural pathways in the central nervous system.</p><p>NPY has a variety effects corresponding to the wide distribution of Y receptors in various tissues. One of the most intriguing actions of NPY is the neuroprotective effects conferred through stimulation neural stem cell proliferation [<a href="#rid72">72</a>]. In this regard, it has been postulated that NPY may offer some protection in neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. Interestingly, NPY appears to be involved in emotional and affective behaviors. In preclinical studies, NPY has been shown to exert anxiolytic and stress-reducing effects through Y1 receptor specific actions and fear extinction and long-term suppression of fear through activation of the Y2 receptor [<a href="#rid73">73</a>]. In the periphery, NPY increases beta cell mass by virtue of NPY receptor expression in pancreatic islets [<a href="#rid74">74</a>].</p><p class="headingAnchor" id="H4274029188"><span class="h2">Diseases</span><span class="headingEndMark"> — </span>A PYY-producing ovarian carcinoid tumor has been associated with severe constipation which may be related to the anti-motility effects of circulating PYY [<a href="#rid75">75</a>]. Under rare conditions in which enteroendocrine cell deficiency may occur, PYY administration may improve nutrient absorption and diminish diarrhea [<a href="#rid76">76</a>].</p><p>A reduction in the abundance of PYY cells in the colon of patients with irritable bowel syndrome has been reported [<a href="#rid77">77</a>]. Interestingly, PYY cells were restored when patients were fed a low fermentable oligo-, di-, and monosaccharides and polyols (FODMAP) diet that was used to reduce their abdominal symptoms. It is not known if PYY contributes to the symptoms of irritable bowel syndrome.</p><p class="headingAnchor" id="H22637512"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>The pancreatic polypeptide (PP) family of peptides includes peptide YY (PYY) and neuropeptide Y (NPY). PP, PYY, and NPY are found in different locations throughout the gastrointestinal tract and nervous system and possess different biological actions. This wide distribution suggests that these peptides regulate many different physiological processes. NPY is a true neurotransmitter, being released from nerve terminals, while PYY and PP are hormones acting in both a paracrine and endocrine manner.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>PP is secreted by specialized pancreatic islet cells (PP cells) that are distinct from those producing insulin, glucagon, or somatostatin. It inhibits pancreatic exocrine secretion. In addition, PP has inhibitory effects on gallbladder contraction and gut motility, and may influence food intake, energy metabolism, and the expression of gastric ghrelin and hypothalamic peptides. (See <a class="local">'Tissue distribution'</a> above and <a class="local">'Physiological actions'</a> above and <a class="local">'Clinical implications of the PP/PYY/NPY family of peptides'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>NPY is a principal neurotransmitter found in the central and peripheral nervous systems and is predominantly found in sympathetic neurons. It is the most potent known stimulant of food intake. Peripherally, NPY affects vascular and gastrointestinal smooth muscle function by binding to the Y1 receptor and through its G protein stimulates phospholipase C, resulting in the accumulation of IP3 and increased cytosolic calcium. (See <a class="local">'Tissue distribution'</a> above and <a class="local">'Physiological actions'</a> above and <a class="local">'Clinical implications of the PP/PYY/NPY family of peptides'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>PYY has been localized to enteroendocrine cells in the mucosa of the gastrointestinal tract and is most highly concentrated in the ileum and colon. PYY inhibits vagally stimulated gastric acid secretion and other motor and secretory functions. PYY-producing cells of the ileum are stimulated by incompletely digested nutrients, particularly fats. PYY released into the bloodstream can inhibit several gastrointestinal processes, including gastric emptying and intestinal motility, thus delaying the delivery of additional food to the intestine. (See <a class="local">'Tissue distribution'</a> above and <a class="local">'Physiological actions'</a> above and <a class="local">'Clinical implications of the PP/PYY/NPY family of peptides'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Kimmel JR, Pollock HG, Hazelwood RL. Isolation and characterization of chicken insulin. Endocrinology 1968; 83:1323.</a></li><li><a class="nounderline abstract_t">Kimmel JR, Hayden LJ, Pollock HG. Isolation and characterization of a new pancreatic polypeptide hormone. J Biol Chem 1975; 250:9369.</a></li><li><a class="nounderline abstract_t">Tatemoto K, Mutt V. Chemical determination of polypeptide hormones. Proc Natl Acad Sci U S A 1978; 75:4115.</a></li><li><a class="nounderline abstract_t">Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci U S A 1982; 79:5485.</a></li><li><a class="nounderline abstract_t">Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982; 296:659.</a></li><li><a class="nounderline abstract_t">Cabrele C, Beck-Sickinger AG. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family. J Pept Sci 2000; 6:97.</a></li><li><a class="nounderline abstract_t">Larsson LI, Sundler F, Håkanson R. Pancreatic polypeptide - a postulated new hormone: identification of its cellular storage site by light and electron microscopic immunocytochemistry. Diabetologia 1976; 12:211.</a></li><li><a class="nounderline abstract_t">Wahlestedt C, Reis DJ. Neuropeptide Y-related peptides and their receptors--are the receptors potential therapeutic drug targets? Annu Rev Pharmacol Toxicol 1993; 33:309.</a></li><li><a class="nounderline abstract_t">Allen YS, Adrian TE, Allen JM, et al. Neuropeptide Y distribution in the rat brain. Science 1983; 221:877.</a></li><li><a class="nounderline abstract_t">Adrian TE, Allen JM, Bloom SR, et al. Neuropeptide Y distribution in human brain. Nature 1983; 306:584.</a></li><li><a class="nounderline abstract_t">Lundberg JM, Tatemoto K, Terenius L, et al. Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci U S A 1982; 79:4471.</a></li><li><a class="nounderline abstract_t">Haber AL, Biton M, Rogel N, et al. A single-cell survey of the small intestinal epithelium. Nature 2017; 551:333.</a></li><li><a class="nounderline abstract_t">Bohórquez DV, Chandra R, Samsa LA, et al. Characterization of basal pseudopod-like processes in ileal and colonic PYY cells. J Mol Histol 2011; 42:3.</a></li><li><a class="nounderline abstract_t">Bohórquez DV, Samsa LA, Roholt A, et al. An enteroendocrine cell-enteric glia connection revealed by 3D electron microscopy. PLoS One 2014; 9:e89881.</a></li><li><a class="nounderline abstract_t">Bohórquez DV, Shahid RA, Erdmann A, et al. Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells. J Clin Invest 2015; 125:782.</a></li><li><a class="nounderline abstract_t">Michel MC, Beck-Sickinger A, Cox H, et al. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 1998; 50:143.</a></li><li><a class="nounderline abstract_t">Eva C, Keinänen K, Monyer H, et al. Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family. FEBS Lett 1990; 271:81.</a></li><li><a class="nounderline abstract_t">Rose PM, Fernandes P, Lynch JS, et al. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem 1995; 270:29038.</a></li><li><a class="nounderline abstract_t">Lee CC, Miller RJ. Is there really an NPY Y3 receptor? Regul Pept 1998; 75-76:71.</a></li><li><a class="nounderline abstract_t">Bard JA, Walker MW, Branchek TA, Weinshank RL. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J Biol Chem 1995; 270:26762.</a></li><li><a class="nounderline abstract_t">Weinberg DH, Sirinathsinghji DJ, Tan CP, et al. Cloning and expression of a novel neuropeptide Y receptor. J Biol Chem 1996; 271:16435.</a></li><li><a class="nounderline abstract_t">Mullins DE, Guzzi M, Xia L, Parker EM. Pharmacological characterization of the cloned neuropeptide Y y(6) receptor. Eur J Pharmacol 2000; 395:87.</a></li><li><a class="nounderline abstract_t">Taylor IL, Impicciatore M, Carter DC, Walsh JH. Effect of atropine and vagotomy on pancreatic polypeptide response to a meal in dogs. Am J Physiol 1978; 235:E443.</a></li><li><a class="nounderline abstract_t">Chen MH, Joffe SN, Magee DF, et al. Cyclic changes of plasma pancreatic polypeptide and pancreatic secretion in fasting dogs. J Physiol 1983; 341:453.</a></li><li><a class="nounderline abstract_t">Holzer P, Farzi A. Neuropeptides and the microbiota-gut-brain axis. Adv Exp Med Biol 2014; 817:195.</a></li><li><a class="nounderline abstract_t">Taylor IL. Distribution and release of peptide YY in dog measured by specific radioimmunoassay. Gastroenterology 1985; 88:731.</a></li><li><a class="nounderline abstract_t">Adrian TE, Ferri GL, Bacarese-Hamilton AJ, et al. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985; 89:1070.</a></li><li><a class="nounderline abstract_t">Ballantyne GH. Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery. Obes Surg 2006; 16:795.</a></li><li><a class="nounderline abstract_t">Shah U, Kowalski TJ. GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders. Vitam Horm 2010; 84:415.</a></li><li><a class="nounderline abstract_t">Rozengurt N, Wu SV, Chen MC, et al. Colocalization of the alpha-subunit of gustducin with PYY and GLP-1 in L cells of human colon. Am J Physiol Gastrointest Liver Physiol 2006; 291:G792.</a></li><li><a class="nounderline abstract_t">Wheway J, Mackay CR, Newton RA, et al. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med 2005; 202:1527.</a></li><li><a class="nounderline abstract_t">Clarke G, Stilling RM, Kennedy PJ, et al. Minireview: Gut microbiota: the neglected endocrine organ. Mol Endocrinol 2014; 28:1221.</a></li><li><a class="nounderline abstract_t">Cani PD, Hoste S, Guiot Y, Delzenne NM. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr 2007; 98:32.</a></li><li><a class="nounderline abstract_t">Everard A, Lazarevic V, Derrien M, et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011; 60:2775.</a></li><li><a class="nounderline abstract_t">Lin TM, Evans DC, Chance RE, Spray GF. Bovine pancreatic peptide: action on gastric and pancreatic secretion in dogs. Am J Physiol 1977; 232:E311.</a></li><li><a class="nounderline abstract_t">Hazelwood RL. The pancreatic polypeptide (PP-fold) family: gastrointestinal, vascular, and feeding behavioral implications. Proc Soc Exp Biol Med 1993; 202:44.</a></li><li><a class="nounderline abstract_t">Adrian TE, Mitchenere P, Sagor G, Bloom SR. Effect of pancreatic polypeptide on gallbladder pressure and hepatic bile secretion. Am J Physiol 1982; 243:G204.</a></li><li><a class="nounderline abstract_t">Asakawa A, Inui A, Yuzuriha H, et al. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 2003; 124:1325.</a></li><li><a class="nounderline abstract_t">Lloyd KC, Grandt D, Aurang K, et al. Inhibitory effect of PYY on vagally stimulated acid secretion is mediated predominantly by Y1 receptors. Am J Physiol 1996; 270:G123.</a></li><li><a class="nounderline abstract_t">Sheikh SP. Neuropeptide Y and peptide YY: major modulators of gastrointestinal blood flow and function. Am J Physiol 1991; 261:G701.</a></li><li><a class="nounderline abstract_t">Wen J, Phillips SF, Sarr MG, et al. PYY and GLP-1 contribute to feedback inhibition from the canine ileum and colon. Am J Physiol 1995; 269:G945.</a></li><li class="breakAll">Mannon P, Taylor IL. The Pancreatic Polypeptide Family. In: Gut Peptides, Biochemistry and Physiology, Walsh JH, Dockray JG (Eds), Raven Press Ltd, New York 1994. p.341.</li><li><a class="nounderline abstract_t">Näslund E, Kral JG. Impact of Gastric Bypass Surgery on Gut Hormones and Glucose Homeostasis in Type 2 Diabetes. Diabetes 2006; 55:S2.</a></li><li><a class="nounderline abstract_t">Sala PC, Torrinhas RS, Giannella-Neto D, Waitzberg DL. Relationship between gut hormones and glucose homeostasis after bariatric surgery. Diabetol Metab Syndr 2014; 6:87.</a></li><li><a class="nounderline abstract_t">Schiellerup SP, Skov-Jeppesen K, Windeløv JA, et al. Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment. Front Endocrinol (Lausanne) 2019; 10:75.</a></li><li><a class="nounderline abstract_t">Lee NJ, Nguyen AD, Enriquez RF, et al. Osteoblast specific Y1 receptor deletion enhances bone mass. Bone 2011; 48:461.</a></li><li><a class="nounderline abstract_t">Wong IP, Driessler F, Khor EC, et al. Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology. PLoS One 2012; 7:e40038.</a></li><li><a class="nounderline abstract_t">Hwa JJ, Witten MB, Williams P, et al. Activation of the NPY Y5 receptor regulates both feeding and energy expenditure. Am J Physiol 1999; 277:R1428.</a></li><li><a class="nounderline abstract_t">Loh K, Herzog H, Shi YC. Regulation of energy homeostasis by the NPY system. Trends Endocrinol Metab 2015; 26:125.</a></li><li><a class="nounderline abstract_t">Pheng LH, Regoli D. Receptors for NPY in peripheral tissues bioassays. Life Sci 2000; 67:847.</a></li><li><a class="nounderline abstract_t">Dimitrijević M, Stanojević S, Vujić V, et al. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors. Regul Pept 2005; 124:163.</a></li><li><a class="nounderline abstract_t">Ueno N, Inui A, Iwamoto M, et al. Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice. Gastroenterology 1999; 117:1427.</a></li><li><a class="nounderline abstract_t">Boey D, Lin S, Enriquez RF, et al. PYY transgenic mice are protected against diet-induced and genetic obesity. Neuropeptides 2008; 42:19.</a></li><li><a class="nounderline abstract_t">Boey D, Lin S, Karl T, et al. Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity. Diabetologia 2006; 49:1360.</a></li><li><a class="nounderline abstract_t">Inui A. Neuropeptide Y feeding receptors: are multiple subtypes involved? Trends Pharmacol Sci 1999; 20:43.</a></li><li><a class="nounderline abstract_t">Kuo LE, Kitlinska JB, Tilan JU, et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 2007; 13:803.</a></li><li><a class="nounderline abstract_t">Broom DR, Batterham RL, King JA, Stensel DJ. Influence of resistance and aerobic exercise on hunger, circulating levels of acylated ghrelin, and peptide YY in healthy males. Am J Physiol Regul Integr Comp Physiol 2009; 296:R29.</a></li><li><a class="nounderline abstract_t">Marsh DJ, Hollopeter G, Kafer KE, Palmiter RD. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med 1998; 4:718.</a></li><li><a class="nounderline abstract_t">Pedrazzini T, Seydoux J, Künstner P, et al. Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat Med 1998; 4:722.</a></li><li><a class="nounderline abstract_t">Naveilhan P, Hassani H, Canals JM, et al. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nat Med 1999; 5:1188.</a></li><li><a class="nounderline abstract_t">Nguyen AD, Herzog H, Sainsbury A. Neuropeptide Y and peptide YY: important regulators of energy metabolism. Curr Opin Endocrinol Diabetes Obes 2011; 18:56.</a></li><li><a class="nounderline abstract_t">Lafferty RA, Flatt PR, Irwin N. Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes. Curr Opin Endocrinol Diabetes Obes 2021; 28:253.</a></li><li><a class="nounderline abstract_t">Shintani M, Ogawa Y, Ebihara K, et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001; 50:227.</a></li><li><a class="nounderline abstract_t">Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature 2001; 409:194.</a></li><li><a class="nounderline abstract_t">Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402:656.</a></li><li><a class="nounderline abstract_t">Inui A. Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nat Rev Neurosci 2001; 2:551.</a></li><li><a class="nounderline abstract_t">Strader AD, Woods SC. Gastrointestinal hormones and food intake. Gastroenterology 2005; 128:175.</a></li><li><a class="nounderline abstract_t">Batterham RL, Cohen MA, Ellis SM, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003; 349:941.</a></li><li><a class="nounderline abstract_t">Nguo K, Walker KZ, Bonham MP, Huggins CE. Systematic review and meta-analysis of the effect of meal intake on postprandial appetite-related gastrointestinal hormones in obese children. Int J Obes (Lond) 2016; 40:555.</a></li><li><a class="nounderline abstract_t">Ahituv N, Kavaslar N, Schackwitz W, et al. A PYY Q62P variant linked to human obesity. Hum Mol Genet 2006; 15:387.</a></li><li><a class="nounderline abstract_t">Stadlbauer U, Woods SC, Langhans W, Meyer U. PYY3-36: Beyond food intake. Front Neuroendocrinol 2015; 38:1.</a></li><li><a class="nounderline abstract_t">Duarte-Neves J, Pereira de Almeida L, Cavadas C. Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases. Neurobiol Dis 2016; 95:210.</a></li><li><a class="nounderline abstract_t">Tasan RO, Verma D, Wood J, et al. The role of Neuropeptide Y in fear conditioning and extinction. Neuropeptides 2016; 55:111.</a></li><li><a class="nounderline abstract_t">Persaud SJ, Bewick GA. Peptide YY: more than just an appetite regulator. Diabetologia 2014; 57:1762.</a></li><li><a class="nounderline abstract_t">Muller KE, Tafe LJ, Gonzalez JL, et al. Ovarian strumal carcinoid producing peptide YY associated with severe constipation: a case report and review of the literature. Int J Gynecol Pathol 2015; 34:30.</a></li><li><a class="nounderline abstract_t">McCauley HA, Matthis AL, Enriquez JR, et al. Enteroendocrine cells couple nutrient sensing to nutrient absorption by regulating ion transport. Nat Commun 2020; 11:4791.</a></li><li><a class="nounderline abstract_t">El-Salhy M, Hatlebakk JG, Hausken T. Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS). Neuropeptides 2020; 79:101973.</a></li></ol></div><div id="topicVersionRevision">Topic 2595 Version 15.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4880986" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Isolation and characterization of chicken insulin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1194289" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Isolation and characterization of a new pancreatic polypeptide hormone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/279902" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Chemical determination of polypeptide hormones.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6957876" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Neuropeptide Y: complete amino acid sequence of the brain peptide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6896083" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10759209" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/782992" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Pancreatic polypeptide - a postulated new hormone: identification of its cellular storage site by light and electron microscopic immunocytochemistry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8494343" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Neuropeptide Y-related peptides and their receptors--are the receptors potential therapeutic drug targets?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6136091" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Neuropeptide Y distribution in the rat brain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6358901" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Neuropeptide Y distribution in human brain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6956876" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29144463" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : A single-cell survey of the small intestinal epithelium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21061049" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Characterization of basal pseudopod-like processes in ileal and colonic PYY cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24587096" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : An enteroendocrine cell-enteric glia connection revealed by 3D electron microscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25555217" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9549761" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2172008" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7499438" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9802395" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Is there really an NPY Y3 receptor?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7592911" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8663568" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Cloning and expression of a novel neuropeptide Y receptor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10794812" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Pharmacological characterization of the cloned neuropeptide Y y(6) receptor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/696866" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Effect of atropine and vagotomy on pancreatic polypeptide response to a meal in dogs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6620187" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Cyclic changes of plasma pancreatic polypeptide and pancreatic secretion in fasting dogs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24997035" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Neuropeptides and the microbiota-gut-brain axis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3838162" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Distribution and release of peptide YY in dog measured by specific radioimmunoassay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3840109" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Human distribution and release of a putative new gut hormone, peptide YY.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16756746" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21094910" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16728727" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Colocalization of the alpha-subunit of gustducin with PYY and GLP-1 in L cells of human colon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16330815" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : A fundamental bimodal role for neuropeptide Y1 receptor in the immune system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24892638" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Minireview: Gut microbiota: the neglected endocrine organ.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17367575" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21933985" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/842664" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Bovine pancreatic peptide: action on gastric and pancreatic secretion in dogs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8380927" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : The pancreatic polypeptide (PP-fold) family: gastrointestinal, vascular, and feeding behavioral implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7114263" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Effect of pancreatic polypeptide on gallbladder pressure and hepatic bile secretion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12730873" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Characterization of the effects of pancreatic polypeptide in the regulation of energy balance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8772509" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Inhibitory effect of PYY on vagally stimulated acid secretion is mediated predominantly by Y1 receptors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1659217" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Neuropeptide Y and peptide YY: major modulators of gastrointestinal blood flow and function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8572226" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : PYY and GLP-1 contribute to feedback inhibition from the canine ileum and colon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8572226" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : PYY and GLP-1 contribute to feedback inhibition from the canine ileum and colon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Impact of Gastric Bypass Surgery on Gut Hormones and Glucose Homeostasis in Type 2 Diabetes</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25152774" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Relationship between gut hormones and glucose homeostasis after bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30863364" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21040809" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Osteoblast specific Y1 receptor deletion enhances bone mass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22792209" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10564216" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Activation of the NPY Y5 receptor regulates both feeding and energy expenditure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25662369" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Regulation of energy homeostasis by the NPY system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10946845" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Receptors for NPY in peripheral tissues bioassays.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15544855" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10579984" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18164057" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : PYY transgenic mice are protected against diet-induced and genetic obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16680491" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10101961" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Neuropeptide Y feeding receptors: are multiple subtypes involved?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17603492" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18987287" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Influence of resistance and aerobic exercise on hunger, circulating levels of acylated ghrelin, and peptide YY in healthy males.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9623983" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Role of the Y5 neuropeptide Y receptor in feeding and obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9623984" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10502824" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21157324" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Neuropeptide Y and peptide YY: important regulators of energy metabolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33395088" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11272130" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11196643" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : A role for ghrelin in the central regulation of feeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10604470" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Ghrelin is a growth-hormone-releasing acylated peptide from stomach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11483998" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Ghrelin: an orexigenic and somatotrophic signal from the stomach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15633135" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Gastrointestinal hormones and food intake.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12954742" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Inhibition of food intake in obese subjects by peptide YY3-36.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26686004" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Systematic review and meta-analysis of the effect of meal intake on postprandial appetite-related gastrointestinal hormones in obese children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16368708" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : A PYY Q62P variant linked to human obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25527432" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : PYY3-36: Beyond food intake.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27461050" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26444585" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : The role of Neuropeptide Y in fear conditioning and extinction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24917132" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Peptide YY: more than just an appetite regulator.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25473750" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Ovarian strumal carcinoid producing peptide YY associated with severe constipation: a case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32963229" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Enteroendocrine cells couple nutrient sensing to nutrient absorption by regulating ion transport.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31727345" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS).</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
